Biotech, Pharma Stocks Surge as IPAB Not Triggered

As noted earlier, biotech and pharmaceutical stocks surged higher mid-day on news the Medicare IPAB cost panel was not triggered this year, pushing it into 2017.

Related Stocks:

• Amgen (NASDAQ: AMGN)
• Biogen (NASDAQ: BIIB)
• Celgene (NASDAQ: CELG)
• iShares Nasdaq Biotechnology (NASDAQ: IBB)
• Regeneron (NASDAQ: REGN)
• SPDR S&P Biotech ETF (NYSE: XBI)
• Gilead Sciences (NASDAQ: GILD)
• Pfizer (NYSE: PFE)
• Allergan (NYSE: AGN)
• Valeant Pharma (NYSE: VRX)
• Merck (NYSE: MRK)
• Endo Int'l (NASDAQ: ENDP)

You May Also Be Interested In

• Amazon's AWS to acquire DuckLabs, maker of DuckDB database
• Senior Iranian Source To Reuters: An Agreement With Oman Over The Strait Of Hormuz Has Not Yet Been Finalised - Reuters
• Rubio tells allies U.S. shifting focus to Iran sanctions - Axios